EPIRUS Biopharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Cash & Short Term Investments
47,924.00
34,640.00
18,008.00
21,462.00
31,515.00
Total Accounts Receivable
1,886.00
3,045.00
2,511.00
-
130.00
Other Current Assets
1,397.00
684.00
223.00
1,556.00
3,602.00
Total Current Assets
51,207.00
38,369.00
20,742.00
23,018.00
35,247.00
Net Property, Plant & Equipment
5,258.00
3,535.00
2,363.00
704.00
2,073.00
Total Investments and Advances
1,872.00
-
1,801.00
1,825.00
1,924.00
Long-Term Note Receivable
-
1,817.00
-
-
-
Intangible Assets
21,546.00
17,654.00
7,200.00
25,468.00
32,771.00
Other Assets
-
-
-
374.00
249.00
Total Assets
79,883.00
61,375.00
32,106.00
51,389.00
72,264.00
ST Debt & Current Portion LT Debt
4,319.00
6,386.00
6,640.00
-
14,833.00
Accounts Payable
1,743.00
3,261.00
2,237.00
2,483.00
2,051.00
Income Tax Payable
-
-
-
185.00
185.00
Other Current Liabilities
9,482.00
9,984.00
6,015.00
4,708.00
16,212.00
Total Current Liabilities
15,544.00
19,631.00
14,892.00
7,376.00
33,281.00
Long-Term Debt
16,258.00
8,781.00
2,132.00
7,282.00
-
Deferred Taxes
-
-
-
2,719.00
1,017.00
Other Liabilities
4,168.00
1,937.00
900.00
1,611.00
1,598.00
Total Liabilities
35,970.00
30,349.00
17,924.00
18,988.00
35,896.00
Common Equity (Total)
43,913.00
31,026.00
14,182.00
32,401.00
36,368.00
Total Shareholders' Equity
43,913.00
31,026.00
14,182.00
32,401.00
36,368.00
Total Equity
43,913.00
31,026.00
14,182.00
32,401.00
36,368.00
Liabilities & Shareholders' Equity
79,883.00
61,375.00
32,106.00
51,389.00
72,264.00
About EPIRUS Biopharmaceuticals
View Profile
